Amrinone, also known as inamrinone, and sold as Inocor, is a pyridine phosphodiesterase 3 inhibitor. [1] It is a drug that may improve the prognosis in patients with congestive heart …

Feb 29, 2024 · Inamrinone, also known as amrinone, is a drug that increases cardiac output through its positive inotropic and vasodilatory effects. It is prescribed for the short-term …

Jul 24, 2007 · Amrinone is a positive inotropic cardiotonic with vasodilator properties, phosphodiesterase inhibitory activity, and the ability to stimulate calcium ion influx into the …

Inamrinone is a prescription medication used for the treatment of congestive heart failure.

Medscape - Indication-specific dosing for amrinone (inamrinone), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and …

Mar 25, 2025 · Inamrinone Injection USP represents a new class of cardiac inotropic agents distinct from digitalis glycosides or catecholamines. Inamrinone lactate is designated …

Amrinone is a novel, nonadrenergic cardiac stimulant that improves myocardial contractility while inducing vasodilation.

Aug 2, 2013 · Amrinone has been a great forerunner of noncatechol and nonglycoside novel cardiotonic agents and given an extraordinary strong impact in the development of novel …

Inamrinone, also known as amrinone, is a drug that increases cardiac output through its positive inotropic and vasodilatory effects. It is prescribed for the short-term management of congestive …

Feb 29, 2024 · Inamrinone, also known as amrinone, is a drug that increases cardiac output through its positive inotropic and vasodilatory effects. It is prescribed for the short-term …